Limited coverage drugs – vortioxetine
Last updated on September 27, 2024
|
Generic name |
vortioxetine hydrobromide |
|
|---|---|---|
|
Strength |
5 mg, 10 mg, and 20 mg |
|
|
Form |
oral tablets |
|
|
Special Authority criteria |
Approval period |
|---|---|
|
Major depressive disorder (MDD) in adult patients AND Treatment failure or intolerance to at least 2 other specified antidepressants for MDD treatment |
Indefinite |
Practitioner exemptions
- None
Special notes
-
Criteria applicable to all plans including Plan